Advanced Therapies UK 2026.

17th March 2026 - 18th March 2026

The Advanced Therapies Congress is Europe’s largest commercial cell and gene therapy conference and exhibition. The event is for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.

The conferences brings together a community of 3,300 global executives at ExCeL London, to be inspired by 300 speakers and 75 start-ups over 2 incredible days.

The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and start- up companies, researchers, clinicians, academics, HTAs, payers and regulators.

Code for 20% off BIOASIA20

RNA Leaders Europe 2026

17th March 2026 - 19th March 2026

RNA Leaders Europe is the leading conference for exploring the future of RNA-based therapeutics and vaccines. Bringing together Europe’s top researchers, biotech innovators, and pharmaceutical leaders, this event dives into cutting-edge advancements in mRNA, siRNA, and antisense technologies.

Discover solutions to delivery challenges, manufacturing hurdles, and commercialisation strategies through expert-led sessions and dynamic networking opportunities.

Whether you’re seeking partnerships or insights, RNA Leaders Europe is your gateway to innovation in RNA medicine.

Don’t miss out, register now and use the 15% discount code (MMBiopharma) to secure your place at this transformative event.

AI Convergence: Small Molecule Discovery Summit 2026

18th March 2026 - 20th March 2026

Arriving in Boston, this March, the inaugural AI Convergence: Small Molecule Discovery Summit will immerse you in the industry-led insights needed to catalyze the next wave of AI/ML-powered small molecule discovery.

Featuring applied talks that provide confidence on small molecule discovery innovation from concept to IND, alongside proven wet lab validation and increased probability of success, walk away feeling empowered to advance better, AI-enabled small molecules to patients faster.

Unite with industry leaders such as Insilico Medicine, Psivant Therapeutics, Sanofi, Novo Nordisk, as well as newcomers including Eli Lilly’s TuneLab, Expedition Medicines and Montai Therapeutics, to ignite future AI/ML-enabled small molecule discovery.

Event dates: March 18-20, 2026

Event location: Hampton by Hilton & Homewood Suites Boston Seaport District, 670 Summer Street, Boston, MA, 02210

11th Innate Killer Summit 2026

23rd March 2026 - 24th March 2026

The 11^th Innate Killer Summit is the only event focused solely on advancing NK and innate immune cell therapies, and this year in particular feels like a real turning point for the field.

The event will spotlight breakthroughs in NK cell engineering, combination strategies, and scalable manufacturing solutions that drive next-generation oncology treatments, alongside regulatory pathways and partnership opportunities that are shaping the field of innate immunity. As Asia accelerates its role in cell therapy development, these insights will be timelier than ever.

Connect with global experts to explore how NK cell platforms are transforming cancer care and unlocking new therapeutic frontiers in one of the world’s most dynamic biopharma markets.

Immune Resetting: B-Cell Mediated & Beyond Summit 2026

23rd March 2026 - 25th March 2026

The Immune Resetting: B-Cell Mediated & Beyond Summit brings together leading minds in immunology and biopharma to explore groundbreaking strategies for immune modulation.

As Asia emerges as a hub for advanced therapeutics, this event dives deep into B-cell biology, precision immunotherapy, and next-generation approaches shaping autoimmune and inflammatory disease treatment.

Attendees will gain actionable insights from global experts, uncover novel mechanisms driving immune resilience, and connect with innovators accelerating clinical translation.

Join us to discover how cutting-edge science is redefining immune resetting and unlocking transformative opportunities for biopharma in one of the fastest-growing healthcare markets worldwide.

LSX World Congress Europe 2026

25th March 2026 - 26th March 2026

For over a decade, the LSX World Congress Europe has been bringing together the executives that matter to the future of healthcare and life science investment, strategy and partnering.

Gathering the founders and CEOs of innovative start-ups through to public healthcare giants. It represents the breadth and depth of cutting-edge research and technology driving the advances in the industry right now and in the near future.

8th Treg-Directed Therapies Summit 2026

24th March 2026 - 26th March 2026

At the 8th Treg-Directed Therapies Summit, Treg experts, including Quell Therapeutics, Nektar Therapeutics, Sanofi, Yale and more, will converge to overcome key challenges from cell targeting, Treg mechanisms of action and cytokine interactions, to indication selection, GMP and regulatory uncertainty, clinical trial design and established efficacy endpoints to push the boundaries of Treg application and clinical success.

Over three action-packed days, enjoy industry-tailored, data-packed presentations and interactive sessions led by pioneering companies unveiling their path to success, to benchmark against the community.

9th Gene Therapy Development Summit 2026

24th March 2026 - 26th March 2026

The 9th Gene Therapy Development Summit returns to Boston as the key meeting point for the global gene therapy community. Join 70+ leaders from Bayer, Astellas, REGENXBIO, AskBio, CureDuchenne and more to connect across pre-clinical development, manufacturing, analytical development, clinical operations and regulatory affairs.

With 10+ dedicated networking breaks, a CEO & Investor Panel and 3 days of strategic and technical sessions, this summit is designed to spark meaningful conversations, restore confidence and build partnerships that accelerate safe, scalable, and impactful gene therapies.

3rd Annual EHS in Biopharma Summit 2026

24th March 2026 - 26th March 2026

Returning to Boston in 2026, the 3rd Annual EHS in Biopharma Summit is the only industry-specific meeting on the East Coast dedicated to uniting Global, Corporate, Vice President and Director-level Environment, Health & Safety leaders across biotech, pharma, CROs and CDMOs.

As the biopharma industry continues its rapid expansion, driven by the rise of radiopharmaceuticals, antibody-drug conjugates, cell and gene therapies, and novel vaccines, EHS professionals are under mounting pressure to scale safety systems, mitigate new biological and chemical risks, and embed sustainability into operations. This year’s meeting provides the strategic foresight and technical depth needed to support this transformation, ensuring zero serious injuries and fatalities in increasingly complex R&D and manufacturing settings.

Join 100+ senior EHS decision-makers from Sanofi, AbbVie, Biogen, AstraZeneca, Charles River Laboratories, Novartis, Jackson Laboratories, Ultragenyx, Genentech, and more to connect, collaborate, and benchmark your strategies against industry leaders tackling the same challenges.

6th Operationalize: Expanded Access Programs Summit 2026

24th March 2026 - 26th March 2026

The 6th Operationalize: Expanded Access Programs Summit returns to Boston in 2026 as the premier forum for access, medical affairs, clinical operations and supply-chain professionals working to turn patient-need into accessible therapies. This event brings together 140+ global experts dedicated to designing, scaling and optimising expanded access and early-access programmes in rare disease, oncology, advanced therapies and emerging markets.

Visionary Faculty Includes:

• AstraZeneca – global access leads tackling regional complexity
• Regeneron Pharmaceuticals – experts turning compassionate-use data into regulatory impact
• Savara Pharmaceuticals – leadership in patient engagement and medical affairs
• The Max Foundation – operators of global access initiatives in emerging markets

Why Attend?

• Three full days of immersive learning, spanning discovery, access strategy and execution
• 30+ expert speakers presenting real-world case studies and actionable frameworks
• 8+ hours of structured networking, connecting with access-leaders, service-providers and regulators
• Dedicated tracks for scaling EAPs, integrating RWD, and managing supply for gene and rare-disease therapies

Join us in Boston and help drive meaningful patient impact through access that’s compliant, scalable and patient-centric.

Next Generation Genomics Congress: Asia 2026

31st March 2026 - 01st April 2026

As molecular diagnostics continues to redefine precision medicine, this inaugural conference will bring together leading experts to explore cutting-edge technologies, analytical approaches and implementation strategies shaping modern healthcare across Asia.

Key Focus Areas:

• Evolving technologies in PCR, NGS and Spatial Omics
• Applications in clinical & translational diagnostics in human health
• Bioinformatics, data interpretation & AI integration
• Applied genomics in microbes and beyond

Poster presentation slot available – Submit your research works and showcase to a global audience

Date: 31 Mar – 1 April 2026

Location: K Lumpur, Malaysia

Get 10% off* and use code: sk10_dg26 or contact saffuan@global-engage.com for inquiry

*not applicable to vendor or service/technology providers

World Vaccine Congress Washington 2026

30th March 2026 - 02nd April 2026

The World Vaccine Congress Washington 2026 is the largest and most established global meeting dedicated to the entire vaccine value chain, spanning from fundamental research to commercial manufacturing and equitable global access. Scheduled for March 30 – April 2, 2026, at the Walter E. Washington Convention Center, this vital event unites over 4,000 attendees from science, government, and industry.

It aims to drive groundbreaking progress and essential partnering in the sector. Key focus areas include Pandemic Platforms, Cancer & Immunotherapy, Emerging Infectious Diseases, Clinical Trials, and Bioprocessing, fostering discussions crucial for the future development and delivery of vaccines worldwide.

Continue reading to use code BPA20 for an extra 20% off.

5th LNP Formulation & Process Development Summit 2026

06th April 2026 - 08th April 2026

Returning to Boston in April 2026, the 5th LNP Formulation & Process Development Summit is an industry-led end-to-end meeting providing the latest scientific content to advance LNP development for a variety of payloads and therapeutic applications, from mRNA vaccines to next-generation cell and gene therapies. This is your one-stop shop to hear insights on LNP discovery, analytics, formulation, process development and large-scale manufacturing.

On a slightly different note, I was wondering if you would be interested in discussing a winder partnership as I am aware that you are in contact with many events, not just my ones, and have been a valued media partner for some time now. Would you be interested in a call next week to see if we can arrange a different type of contract that means we no longer have to reach out to you individually?

4th Cell & Gene Therapy Innovation & Access Congress 2026

09th April 2026 - 10th April 2026

Now in its fourth year, the event returns with strong demand and a refreshed focus covering the full cell and gene therapy pipeline—from early-stage research to manufacturing and scalability. Over two days, the conference will bring together 30+ expert speakers and more than 150 participants, supported by an exhibition and networking area featuring 20+ sponsors and solution providers.

The programme runs across two dedicated tracks: Therapeutic Discovery & Engineering, highlighting innovations in gene therapy and next-generation cell therapies; and Manufacturing Enablement & Translation, focusing on advances in gene therapy manufacturing and scalable solutions for cell therapy production.

Date: 9-10 April 2026

Location: Seoul, South Korea

3rd GLP-1 Based Therapeutics Summit 2026

14th April 2026 - 16th April 2026

The 3rd GLP-1 Based Therapeutics Summit is the essential industry forum dedicated to solving the critical challenges of GLP-1 combinations, mastering tolerability, drug delivery, and seizing the multi-billion dollar opportunity in non-obesity indications.

This year, we’re diving deep into the game-changing potential of multi-agonist combinations, next-generation tolerability, and strategic commercial planning.

Hear from the titans of the pharmaceutical industry, including Eli Lilly, AstraZeneca, Merck, and Takeda, as well as innovative biotechs and financial institutions who will share their groundbreaking research and strategies for developing best-in-class treatments that transform patient lives.

The inaugural Oligonucleotides for CNS Summit Europe 2026

21st April 2026 - 23rd April 2026

The inaugural Oligonucleotides for CNS Summit Europe will unite 60+ senior industry leaders for the first European forum dedicated exclusively to CNS-focused oligonucleotide therapeutics.

The summit delivers three days of highly technical, data-driven discussions addressing the challenges unique to CNS development, with insights into next-generation BBB delivery strategies beyond TfR1, advanced in vivo and iPSC models, novel chemistry and conjugation approaches, and translational strategies bridging preclinical data to clinical and regulatory success.

To find out more, continue reading…

11th Microbiome R&D and Business Collaboration Congress and 2nd Skin Health & Microbiome 2026

29th April 2026 - 30th April 2026

The two-day conference will gather over 40 speakers and 200 attendees, featuring innovative start-up flash presentation sessions designed to spark new ideas and development. Programme topics span the role of the microbiome in health and disease, including the impact of diet and nutrition, pre-, pro- and postbiotics, and emerging insights into the gut-brain axis and other body sites.

Sessions also cover microbiome-based therapeutics, technological advances such as AI, machine learning and bioinformatics, as well as skin health, ageing, hydration, and the hair and scalp microbiome. Cross-disciplinary approaches and environmental influences on the skin microbiome complete the programme.

Date: 29-30 April 2026

Location: Singapore

Cell & Gene Meeting on the Mediterranean 2026

28th April 2026 - 30th April 2026

The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond.

Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 50+ dedicated presentations by leading publicly traded and privately held companies in the space.

5th ADC Analytical Development Summit 2026

28th April 2026 - 30th April 2026

The 5th ADC Analytical Development Summit is the only dedicated platform for tackling the unique analytical complexities of ADC development.

Optimizing ADC Physiochemical, Potency, & Impurity Analytical Methods to Enhance Product Understanding, Quality & Assess DARs for Regulatory Submissions.

The ADC landscape is undergoing a rapid transformation with novel modalities like bispecifics, dual payload conjugates, and novel conjugates all push the boundaries of innovation, whilst more traditional ADCs are progressing their way through the pipelines.

The 5th ADC Analytical Development Summit is your essential, technical, forum to unite with your analytical development peers and senior decision makers.

3rd Peptide-Based Therapeutics Summit 2026

28th April 2026 - 30th April 2026

Advance your global pipeline at the industry’s premier peptide forum in Boston. Join 100+ stakeholders from Merck, AbbVie, and Chugai Pharmaceuticals to accelerate peptide drug discovery, CMC, and formulation.

As the dedicated platform for next-generation therapies, this summit explores novel computational screening, oral delivery, and bioavailability strategies to improve clinical efficacy.

Network with US and international leaders in medicinal chemistry and pharmacology to bridge the gap from concept to commercialization. Don’t miss this opportunity to define the future of the “goldilocks modality.”

GENAP Summit 2026

05th May 2026 - 06th May 2026

The GENAP Summit 2026 returns as a premier platform for advancing pharmaceutical manufacturing, aseptic processing, and Gene & Cell Therapy (GCT) innovations. As the industry accelerates toward automation, regulatory transformation, and breakthrough therapies, GENAP 2026 will provide unparalleled insights, case studies, and forward-thinking discussions.

7th Gene Therapy Analytical Development Summit Europe 2026

05th May 2026 - 07th May 2026

The 7th Gene Therapy Analytical Development Summit Europe returns to London in May 2026 as the leading forum uniting 60+ senior experts from biotech, pharma, and regulatory authorities to advance analytical rigour across gene therapy pipelines.

With programmes rapidly progressing into late‑stage development and regulatory review, the summit delivers peer‑led insights on strengthening analytical strategy, QC, and potency assurance to meet evolving EMA expectations.

Attendees will hear from innovators including Complement Therapeutics, MeiraGTx, PureSpring Therapeutics, Orchard Therapeutics, UCB and the MHRA, as they share practical solutions for comparability, potency assay development, and analytical readiness.

This is your opportunity to connect with empowering teams to accelerate safe, consistent gene therapies from clinic to market.

3rd Measuring Patient Engagement Summit 2026

05th May 2026 - 07th May 2026

The 3rd Measuring Patient Engagement Summit is the only industry event dedicated to transforming patient‑engagement efforts into measurable, actionable impact.

Bringing together 70+ senior leaders from pharma, biotech, and patient advocacy, the summit explores frameworks, tools, and evidence‑based approaches that demonstrate how patient insights drive outcomes across development, access, and commercialization.

Across three days of workshops, case studies, and collaborative discussions, attendees will learn to move beyond anecdotal reporting, benchmark strategies, track multi‑year engagement impact, and clearly demonstrate ROI to regulators and internal stakeholders. The summit empowers teams to elevate patient engagement from activity to strategic value creation.

TIDES USA 2026

11th May 2026 - 14th May 2026

TIDES USA is the flagship global conference for oligonucleotide, peptide, mRNA, and gene therapy development, joining 1900+ global leaders.

It serves as the ultimate platform for industry leaders, researchers, and innovators to explore cutting-edge advancements in drug discovery, development, and manufacturing.

With a comprehensive agenda covering scientific breakthroughs, regulatory insights, and emerging technologies, TIDES USA fosters collaboration and provides unparalleled networking opportunities to drive the future of biotherapeutics on a global scale.

Dates: May 11-14, 2026
Location: Hynes Convention Center, Boston, MA

Use Code: BioParmaAsia10 for an extra 10% off

Global Drug Delivery and Formulation (DDF) Summit 2026

18th May 2026 - 20th May 2026

The Global Drug Delivery and Formulation (DDF) Summit is Europe’s premier gathering for professionals at the forefront of pharmaceutical development and drug delivery science. Now in its 17th year, the Summit has earned a reputation for delivering exceptionally high-quality content, shaped by market research, industry trends and direct feedback from past attendees to ensure relevance and impact.

Over three days in Berlin, the Summit brings together senior scientists, researchers and industry leaders from around the world for more than 100 scientific presentations, four specialist content streams and a competitive poster programme.

Sessions span Small Molecules, Biologics, Technology & Innovation and Device Development, offering deep insight into current challenges and emerging opportunities in formulation science and drug delivery.

7th TCR Based Therapies Summit 2026

18th May 2026 - 20th May 2026

The 7th TCR‑Based Therapies Summit is your pivotal industry-focused meeting uniting global leaders advancing T‑cell receptor–based cell and biologic therapies.

Taking place this May, in Boston, we will delve into the field’s most urgent scientific, translational, and commercial challenges, to support the progression of durable, scalable TCR therapies to the clinic and beyond.

Attendees will hear first-hand from experts developing novel engineering strategies, utilizing next-generation target discovery, exploring AI‑driven optimization and new platform innovations. Join senior experts from Immunocore, Immatics, Regeneron, Enara Bio, and Zelluna Immunotherapy, to gain the industry know-how to advance TCR-based platforms from discovery through to clinical development and commercialization.

7th Dermatology Drug Development Summit Europe 2026

19th May 2026 - 21st May 2026

The 7th Dermatology Drug Development Summit Europe brings together leading pharma and biotech teams to accelerate clinical progress for small molecules and biologics targeting both rare and common skin diseases.

With late‑stage pipelines expanding across conditions such as atopic dermatitis, psoriasis, hidradenitis suppurativa, and vitiligo, the event focuses on overcoming regulatory hurdles, reducing Europe’s post‑approval access delays, and improving trial design amid high placebo effects.

Offering 3 days of case studies, workshops and over 6 hours of networking time, attendees will gain practical insights into advanced imaging, biomarkers, AI‑enabled trial design, and real‑world evidence strategies. To learn more, continue reading…

10th Digital Pathology & AI Congress: Asia 2026

28th May 2026 - 29th May 2026

Co-hosted with the Vietnam Society of Pathology and Cytology the 10th Congress will explore:

• Strategies, technologies, and real-world applications of digital pathology
• Next-generation computational pathology powered by AI
• AI-driven imaging and digital image analysis
• Innovations in imaging technologies
• Emerging technologies and AI-enabled treatment approaches

This dynamic programme is featuring keynote presentations, panel discussions and poster sessions, all designed to showcase the latest innovations and practical applications in digital pathology and artificial intelligence.

5th Extrahepatic Lipid-Based Nanoparticles Delivery Summit 2026

02nd June 2026 - 04th June 2026

The 5th Extrahepatic Lipid-Based Nanoparticles Delivery Summit returns to Boston in June 2026 as the leading event focused on advancing extrahepatic LNP delivery and targeted lipid nanoparticle technologies.

Bringing together 60+ experts from biopharma and academia, this three-day summit will explore novel targeting ligands, formulation strategies, and scalable manufacturing approaches to enable precise, tissue-specific delivery beyond the liver.

With growing industry momentum, including strategic investments from AbbVie and Bristol Myers Squibb, discussions will accelerate mRNA, RNA, gene-editing, and cell therapy delivery to immune cells, muscle, and adipose tissue. Gain insights into LNP analytics, immunogenicity, and clinical translation.

5th ALS Drug Development Summit 2026

02nd June 2026 - 04th June 2026

Uniting 100+ key ALS and FTD stakeholders across pharma, biotech, academia, patient and caregiver communities, key research funding organizations and advocacy groups, the 5th ALS Drug Development Summit is the ultimate platform honing industry R&D for safer, more effect and patient-relevant drugs that serve the community, driving a cure for sporadic and familial ALS.

With 30+ expert speakers and a program spanning early target exploration through to clinical design, biomarker strategy, and regulatory engagement, attendees will gain comprehensive insights into genetically validated targets, the evolving biology of TDP 43, adaptive trial design, and embedding the patient voice throughout development.

Date: June 2-4, 2026

Location: Boston, MA

World Orphan Drug Congress USA 2026

09th June 2026 - 11th June 2026

The World Orphan Drug Congress is the largest global event dedicated to rare diseases and orphan drug innovation, bringing together more than 2,000 attendees, 280 speakers, and 100 exhibitors.

It unites industry leaders, scientists, regulators, and patient advocates to explore breakthroughs in cell and gene therapies, clinical development for small populations, regulatory strategies, global market access, and real-world evidence.

The event offers deep insights into improving diagnostics, advancing cutting-edge treatments, and expanding equitable access for patients worldwide. With expert sessions, hands-on workshops, and extensive networking, it is a premier forum for driving progress across the full rare disease value chain.

Discount code: BPA20

World TPD & Induced Proximity Summit South Korea 2026

09th June 2026 - 11th June 2026

The inaugural World TPD & Induced Proximity Summit South Korea is an exclusive opportunity to connect with global pharma, including Astellas and Amgen, leading biotechs such as Ubix Therapeutics and Degron Therapeutics, and local leaders like Tanabe Pharma, FIMECS, and more to develop best-in-class TPD therapeutics.

Featuring key international opinion leaders, deep dives into preclinical and clinical strategy, and expanded content on molecular glues and novel E3 ligases, this summit is your chance to de-risk your pipelines, learn from international experts, and build the global collaborations needed to advance best-in-class TPD therapeutics.

Part of the World Targeted Therapeutics Summit in South Korea by Hanson Wade, this is your opportunity to converge with peers working on antibody-drug conjugates (ADCs), Bispecifics, and T-cell engagers, who aim to turn South Korea into the next major global hub for biopharma innovation in targeted therapeutics.

5th World ADC Summit South Korea 2026

09th June 2026 - 11th June 2026

The 5th World ADC Summit South Korea (previously World ADC Asia) is returning to provide you with the most comprehensive platform for South Korea’s rapidly growing ADC community. Join the likes of Daiichi Sankyo, Astellas, Gilead, AbbVie, Kanaph Therapeutics, OBI Pharma, Aimed Bio, Huadong Medicine, and more, for end-to-end insights on the evolving ADC landscape, novel technologies, dual payloads, and bispecific ADCs to further your ADC development.

This is the only ADC meeting in South Korea dedicated to bringing together global leaders from across the ADC industry with end-to-end industry knowledge. This is a must-attend meeting for anyone in South Korea looking to further their ADC development to be first and best-in-class.

Part of the World Targeted Therapeutics Summit in South Korea by Hanson Wade, this is your opportunity to converge with peers working on targeted protein degradation (TPDs), Bispecifics, and T-cell engagers, who aim to turn South Korea into the next major global hub for biopharma innovation in targeted therapeutics.

World Targeted Therapeutics Summit South Korea 2026

09th June 2026 - 11th June 2026

The World Targeted Therapeutics South Korea Summit by Hanson Wade is a brand-new event experience delivering a comprehensive three-day coverage of the hottest topics in oncology by uniting three conferences together in the same venue at the same time: the 5th World ADC South Korea Summit, the World TPD & Induced Proximity Summit South Korea, and the World Bispecific & T-Cell Engager Summit South Korea.

This is a unique opportunity to focus on differentiated platforms and pipelines to create future first-and-best-in-class therapeutics that make you stand out from your competition and more appealing for global pharma partnerships.

Acting as Korea’s most comprehensive R&D forum, join 450+ of your peers to transform the future and position South Korea as a global leader in targeted therapeutic R&D with both a strategic overview and technical insights across discovery, preclinical translation, clinical development, and manufacturing in each field.

7th Supply Chain & Logistics for Cell & Gene Therapies Summit 2026.

09th June 2026 - 11th June 2026

The 7th Supply Chain & Logistics for Cell & Gene Therapies Summit is returning to Washington, DC this June 9-11. Bringing together global pharma, biotech, and clinical leaders to tackle the growing operational challenges of advanced therapy supply chains.

This summit will focus on building resilient, scalable, and digitally enabled networks amid rising tariffs, evolving regulations, and capacity constraints.

Through case studies, workshops, and expert-led sessions, attendees can explore end‑to‑end visibility, regulatory navigation, next‑generation manufacturing models, and real‑world strategies for reliable scale‑up.

To equip your teams with practical frameworks to safeguard product integrity and support clinical and commercial readiness, sign up here…

3rd Global Cell and Gene Therapy Summit 2026

06th July 2026 - 08th July 2026

The 3rd Global Cell and Gene Therapy Summit 2026 is a premier event bringing together experts, researchers, and industry leaders to explore the latest advancements in cell and gene therapy. The summit will feature thought-provoking sessions, case studies, and networking opportunities to foster innovation, collaboration, and strategic partnerships in the rapidly evolving landscape of biopharmaceutical science.

5th In Vivo Cell Engineering & Gene Editing Summit 2026

28th July 2026 - 30th July 2026

The 5th In Vivo Cell Engineering & Gene Editing Summit is the leading global meeting dedicated to advancing targeted in vivo delivery, next-generation editing technologies, and emerging clinical data.

Uniting pioneering biopharma, investors, and scientific leaders, the summit explores breakthroughs in extrahepatic delivery, enhanced specificity and durability, and first-in-human readouts that are defining the field’s rapid evolution.

With a dedicated focus on Asia’s accelerating clinical ecosystem and partnerships, attendees gain practical insights to advance programs toward scalable, safer, and more accessible in vivo therapies. Join the community shaping the future of cell and gene engineering.

ISPE Singapore Conference & Exhibition 2026

19th August 2026 - 21st August 2026

The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals. The annual meeting highlights best practices and services – from manufacturing facility design to finished product.

This is your opportunity to gather the latest updates and knowledge from your industry colleagues and subject matter experts!

RNA Leaders APAC 2026

01st September 2026 - 02nd September 2026

RNA Leaders APAC is the go-to event for advancing RNA-based therapeutics and vaccines in the Asia-Pacific region. With a focus on the region’s growing biotech hubs and unique industry needs, this conference explores innovations in mRNA, siRNA, and antisense technologies.

Attendees will gain insights into overcoming delivery hurdles, navigating diverse regulatory environments, and scaling manufacturing for APAC markets.

Featuring expert-led sessions and tailored networking opportunities, RNA Leaders APAC connects global experts with local innovators to drive RNA advancements in this dynamic region.

Don’t miss out, register now and use the 15% discount code (MMBipPharma) to secure your spot.

16th American Drug Delivery & Formulation Summit 2026

14th September 2026 - 15th September 2026

The 16th American Drug Delivery & Formulation Summit brings together an outstanding faculty of industry-leading speakers for two days of high-level scientific and strategic insight. Now firmly established as a must-attend event, the summit continues to grow year on year, welcoming over 450 scientific and industry leaders from pharma, biotech, and drug delivery organizations in its most recent edition.

Attendees will engage with a comprehensive program addressing critical challenges, emerging technologies, and formulation strategies shaping the future of drug delivery. Extensive networking opportunities foster meaningful connections, collaboration, and business growth across the global drug delivery community.

World Patient Safety Congress Europe 2026

22nd September 2026 - 24th September 2026

The World Patient Safety Congress Europe (formerly known as World Drug Safety Congress Europe is the premier global marketplace for C-suite executives, R&D specialists, and data leaders to define the future of pharmacovigilance and patient safety.

Taking place from September 22–24, 2026, at the RAI Amsterdam, this event explores the intersection of drug safety strategy and technological disruption.

This premier event brings together over 1,800 leaders from pharma, biotech, and regulatory bodies to explore the future of pharmacovigilance.

The congress features over 250 speakers and 10 content tracks focusing on the role of AI, automation, and Real-World Evidence (RWE) in safety monitoring and risk management.

By bringing together international regulatory bodies, industry professionals, and patient representatives, the event aims to foster a collaborative culture of innovation that improves safety outcomes across pharmaceutical drugs, medical devices, and consumer products

RNA Leaders USA 2026

23rd September 2026 - 25th September 2026

RNA Leaders USA is the premier event for advancing RNA-based therapeutics and vaccines in North America. Join leading scientists, biotech innovators, and pharmaceutical experts as they explore the latest breakthroughs in mRNA, siRNA, and antisense technologies.

This conference tackles key challenges in drug development, delivery systems, and large-scale manufacturing, offering actionable insights and opportunities for collaboration.

With thought-provoking panels and networking sessions, RNA Leaders USA is the ultimate platform for driving innovation in RNA medicine.

Register today and use the 15% discount code (MMBiopharma) to be part of the movement shaping the future of healthcare.

Cell & Gene Meeting on the Mesa 2026

05th October 2026 - 07th October 2026

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference, bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.

Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies.

The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 110+ dedicated presentations by the leading publicly traded and privately held companies in the space.

4th Spatial Biology Congress co-located with 3rd Single Cell Congress: Asia 2026.

13th October 2026 - 14th October 2026

Global Engage is proud to announce the 4th Spatial Biology Congress Asia, returning on 13th and 14th October 2026 as part of a dual-track meeting in Singapore. This congress brings together leaders in spatial biology, imaging, bioinformatics and multi-omics technologies to explore the latest methods and applications transforming biological insights and translational medicine.

Over two days, delegates will benefit from expert-led presentations, panel discussions, and interactive sessions focused on spatial biology innovations, from high-plex imaging and dataset to cutting-edge analysis pipelines as well as insights to advance biomarker discovery, disease research, and clinical applications.

As part of the dual-track format, delegates can also engage with the 3rd Single Cell Congress: Asia, fostering cross-disciplinary learning and collaboration across spatial and single-cell technologies.

10% off* – Promo code: SK10_sb26

* Limited seats offer, first-come-first-serve basis, and not applicable to vendor or service/technology provider/supplier category

FormuTech Summit 2026

14th October 2026 - 15th October 2026

The FormuTech Summit brings together over 80+ senior industry experts, uniting leaders in the pharmaceutical and biotechnology sectors, as well as academia, to redefine mRNA process development, LNP formulations, and manufacturing.

Key topics include empowering mRNA advancements to ensure efficiency and therapeutic relevance, mastering LNP characterization for enhanced efficacy and safety, and overcoming global manufacturing challenges to build a resilient production landscape.

World Patient Safety Congress Americas 2026

13th October 2026 - 15th October 2026

The World Patient Safety Congress Americas (formerly known as World Drug Safety Congress Americas) is the premier global marketplace for C-suite executives, R&D specialists, and data leaders to define the future of pharmacovigilance and patient safety.

Taking place from October 13-15, 2026, at the Thomas M.Menino Convention & Exhibition Center, Boston, this event explores the intersection of drug safety strategy and technological disruption.

This premier event brings together over 1,800 leaders from pharma, biotech, and regulatory bodies to explore the future of pharmacovigilance.

The congress features over 250 speakers and 10 content tracks focusing on the role of AI, automation, and Real-World Evidence (RWE) in safety monitoring and risk management.

By bringing together international regulatory bodies, industry professionals, and patient representatives, the event aims to foster a collaborative culture of innovation that improves safety outcomes across pharmaceutical drugs, medical devices, and consumer products.

World Vaccine Congress Europe 2026

19th October 2026 - 21st October 2026

The World Vaccine Congress Europe will bring together more than 2,000 attendees, 280 speakers and over 150 exhibitors and start-ups for a comprehensive exploration of the vaccine ecosystem.

The event features presentations from leading global organizations including WHO, PATH, GSK, Moderna and CEPI, alongside panel debates addressing key scientific and policy challenges.

Attendees can benefit from extensive networking through dedicated breaks and receptions, connect with solution providers in a broad exhibition area, and engage in a dynamic start-up zone designed to link innovators with investors seeking promising early-stage vaccine technologies and fostering collaboration across the global vaccine community for progress.

Discount code: BPA20

2nd Precision Medicine Congress: Asia 2026

21st October 2026 - 22nd October 2026

Be part of Precision Medicine Asia 2026, a two-day conference scheduled for October 21-22, 2026, in Taiwan. This exceptional event will gather top experts, innovators, and industry leaders to explore the transformative possibilities of precision medicine and drug discovery in Asia.

Uncover the extraordinary potential of precision medicine at this year’s annual conference, where tailored treatments, based on genetics, environment, and lifestyle factors, take the spotlight.

This dynamic programme is featuring keynote presentations, panel discussions and poster sessions, all designed to showcase the latest innovations and practical applications in precision medicine area.

10% off* – Promo code: SK10_pm26

* Limited seats offer, first-come-first-serve basis, and not applicable to vendor or service/technology provider/supplier category

Global RESCON Summit 2026

10th November 2026 - 11th November 2026

The Global RESCON Summit is a prestigious and highly anticipated event, building on the success of previous editions in New York, Porto, Barcelona, and San Francisco.

Dedicated to Inhalation & Respiratory Drug Delivery | Connected Devices, the summit brings together world-leading experts from the pharmaceutical and biotechnology sectors, device manufacturers, material innovators, and academia.